The Roche towers in Basel. The pharmaceutical group overtook electrical engineering group ABB to claim first place for patent applications in Switzerland.
Keystone / Georgios Kefalas
Swiss companies filed almost seven times as many patent applications per million inhabitants last year as companies in the United States. The medical technology sector led the field.
After a slight decline due to Covid in 2020, patent applications in Europe rose again last year, the European Patent Office (EPO) said in a statementExternal link on Tuesday.
The Munich-based body received a total of 188,600 patent applications in 2021, an increase of 4.5% year-on-year, setting a new record. It registered 8,442 patent applications from Switzerland, up 3.9%.
The US remains the country with the highest number of patent applications (46,553), while patent filings from Chinese companies “continued to climb steeply”, increasing by 24% last year (16,665), the EPO said.
Per million inhabitants, however, Switzerland remains way out in the lead with 969 patent applications, followed by Sweden (488), Denmark (454), the Netherlands (383) and Finland (380). The US had 140 applications per million inhabitants and the UK 82.
More
More
Switzerland ranks among world leaders for trademark and patent filings
This content was published on
A record number of international patents were filed last year despite the Covid-19 pandemic.
At the European level the digital communication and information technology sector filed the most applications (15,400, 9.4%), followed by medical technology (15,231, 8.8%) and computer technology (14,671, 9.7%).
In Switzerland the medical technology sector applied for the most patents. This was followed by the consumer goods, metrology, electronic devices and machines, pharmaceuticals, chemistry and biotechnology sectors.
Among Swiss companies, Basel-based pharmaceutical group Roche overtook electrical engineering group ABB in first place. The two tobacco companies Japan Tobacco and Philip Morris were followed by Nestlé and Swatch Group.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Genome editing’s patent problem fuels concern for the future of food
This content was published on
Genome editing is touted as a solution to feeding a planet battered by climate change. But an outdated patent system could stifle its potential.
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
Legal victory for Lindt in German chocolate bunny case
This content was published on
The Federal Court of Justice delivered its verdict on Thursday in a battle between Lindt and German company Heilemann, which in 2018 also marketed a chocolate bunny in a gold foil wrap. Lindt claimed it had a trademark on the colour, acquired by use, and that Heilemann had infringed this trademark and should be prevented…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.